|
Tuesday, March 1 — 8:00 AM — CC 008 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section C - Breast Pathology
Chaired by: W. Fraser Symmans and Melinda Sanders
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Identification of Molecular Subtypes of Breast Cancer Using Hierarchical Clustering: Analysis of Inter-Observer Agreement.
(212)
A Mackay, B Weigelt, A Grigoriadis, B Kreike, R Natrajan, R A'Hern, DS Tan, M Dowsett, A Ashworth, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; CRUK London Research Institute, United Kingdom; KCL Breakthrough Breast Cancer Research Unit, London, United Kingdom; Institute for Radiation Oncology, Arnhem, Netherlands
|  Add |
| 8:15 |
Molecular Classification of Screen Detected Breast Cancers.
(150)
G Farshid, A Walker, G Battersby - BreastScreen SA, Wayville, SA, Australia; SA Pathology, Adelaide, SA, Australia
| Add |
| 8:30 |
Lymphovascular Breast Carcinoma Tumoral Emboli Form through Stem Cell Initiated Self-Budding Histogenesis.
(102)
SH Barsky, Y Ye, JD Tellez, M Belcher, FM Robertson - University of Nevada School of Medicine and Nevada Cancer Institute, Reno; University of Texas MD Anderson Cancer Center, Houston
| Add |
| 8:45 |
Absence of Histologic Differences between Benign Breast Tissue from BRCA Carriers and Controls Despite Differential Gene Expression.
(153)
L Feeley, L Bordeleau, S Richter, F O'Malley, D Pinnaduwage, L Collins, B Youngson, G Glendon, M Musgrave, J Mahoney, W Leong, J Lipa, D McCready, I Andrulis, AM Mulligan - St Michael's Hospital, Toronto, Canada; University of Toronto, ON, Canada; Oncology, McMaster University, Hamilton, Canada; Cancer Care Ontario, Toronto, Canada; University of California, Los Angeles, Canada; Samuel Lunenfeld Research Institute, Toronto, Canada
| Add |
| 9:00 |
Minimal Residual Disease in Blood and Bone Marrow in Lymph Node Negative Early Stage Breast Cancer.
(196)
S Krishnamurthy, A Lodhi, C Hall, S Jackson, A Anderson, A Bhattacharya, B Singh, A Lucci - MD Anderson Cancer Center, Houston, TX
| Add |
| 9:15 |
Lymph Node Status of Triple Negative Breast Carcinoma: Results of a Large Cohort Study.
(285)
YH Wen, G Gupta, Z Bowser, A Ho, E Brogi - Memorial Sloan-Kettering Cancer Center, New York, NY
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
A New Pathological Response Index (PRI) for Neoadjuvant Chemotherapy Accurately Predicts Clinical Outcomes of Locally Advanced Primary Breast Cancers (LAPBC).
(91)
TMA Abdel-fatah, PM Mosley, A Lee, S Pinder, JS Reis-Filho, IO Ellis, SY Chan - School of Molecular Medical Science, Nottingham University City Hospitals, United Kingdom; Kings College London, Guy's and St Thomas'Hospitals, London, United Kingdom; Institute of Cancer Research, London, United Kingdom
| Add |
| 11:15 |
Classifications of Pathological Response and Long-Term Follow-Up in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
(133)
AD Corben, C Teo, R AbiRaad, A Bombonati, FC Koerner, A Taghian, EF Brachtel - Memorial Sloan-Kettering Cancer Center, New York, NY; Tan Tock Seng Hospital, Singapore, Singapore; Massachusetts General Hospital and Harvard Medical School, Boston
| Add |
| 11:30 |
Neoadjuvant Treatment of Breast Carcinoma Does Not Affect the Accuracy of Intraoperative Sentinel Lymph Node Evaluation.
(239)
HT Richard, DL Johnson, MO Idowu, CN Powers - Virginia Commonwealth University, Richmond
| Add |
| 11:45 |
Comparison of Tumor Biomarker Expression in Breast Cancer Patients before and after Neoadjuvant Chemotherapy.
(130)
A Cockburn, Y Fang, Y Peng, B Haley, V Sarode - University of Texas Southwestern, Dallas
| Add |
|
|
